Fluoxetine, a widely used antidepressant that primarily acts as a selective serotonin reuptake inhibitor, also inhibits various neuronal ion channels. Using the whole-cell patch-clamp technique, we have examined the effects of fluoxetine and norfluoxetine, its major active metabolite, on cloned low-voltageactivated T-type calcium channels (T channels) expressed in tsA 201 cells. Fluoxetine inhibited the three T channels Ca V 3.1, Ca V 3.2, and Ca V 3.3 in a concentration-dependent manner (IC 50 ϭ 14, 16, and 30 M, respectively). Norfluoxetine was a more potent inhibitor than fluoxetine, especially on the Ca V 3.3 T current (IC 50 ϭ 5 M). The fluoxetine block of T channels was voltage-dependent because it was significantly enhanced for T channels in the inactivated state. Fluoxetine caused a hyperpolarizing shift in steady-state inactivation, with a slower rate of recovery from the inactivated state. These results indicated a tighter binding of fluoxetine to the inactivated state than to the resting state of T channels, suggesting a more potent inhibition of T channels at physiological resting membrane potential. Indeed, fluoxetine and norfluoxetine at 1 M strongly inhibited cloned T currents (ϳ50 and ϳ75%, respectively) in action potential clamp experiments performed with firing activities of thalamocortical relay neurons. Altogether, these data demonstrate that clinically relevant concentrations of fluoxetine exert a voltage-dependent block of T channels that may contribute to this antidepressant's pharmacological effects.
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Fluoxetine (Prozac; Eli Lilly & Co., Indianapolis, IN) is a psychoactive drug widely prescribed in many psychiatric disorders, including depression, obsessive-compulsive disorder and bulimia nervosa. Like most antidepressants, fluoxetine causes side effects including nausea, gastrointestinal complaints, headaches, anxiety, insomnia, drowsiness, and loss of appetite (Cookson and Duffett, 1998) . Fluoxetine is metabolized via the cytochrome P450 enzyme system (Stark et al., 1985; Wong et al., 1995) into multiple metabolites, including norfluoxetine, the major active metabolite, with pharmacological properties that are similar to or more potent than those of the parent drug (Hiemke and Hartter, 2000) . The therapeutic action of fluoxetine primarily results from the inhibition of serotonin reuptake (Stark et al., 1985; Wong et al., 1995) , thus enhancing serotoninergic neurotransmission. Besides this mechanism, fluoxetine has several other modulatory effects, such as inhibition of G protein-coupled receptors (Stanton et al., 1993; Palvimaki et al., 1996) , blockade of monoamine oxidases (Mukherjee and Yang, 1999) , and modulation of several ionic channels. Indeed, it has been reported that fluoxetine is a potent blocker of K ϩ channels (Thomas et al., 2002; Choi et al., 2003; Kobayashi et al., 2003; Kennard et al., 2005) , Na ϩ channels (Pancrazio et al., 1998) , and Ca 2ϩ channels (Deak et al., 2000) . T-type Ca 2ϩ channels, a subgroup of voltage-gated Ca 2ϩ channels, are the target of many antipsychotic drugs, including penfluridol, clozapine, fluspiriline, haloperidol, and pimozide (Enyeart et al., 1992; Santi et al., 2002; Yunker, 2003) . After the study by Deak et al. (2000) reporting that fluoxetine inhibits T-type Ca 2ϩ currents in rat hippocampal pyramidal cells, it is of importance to characterize fluoxetine's action on the three T-type Ca 2ϩ channel subtypes (Ca V 3.1 or ␣ 1G , Ca V 3.2 or ␣ 1H , and Ca V 3.3 or ␣ 1I ) that have been characterized recently by molecular cloning and patch-clamp techniques Perez-Reyes et al., 1998; Klugbauer et al., 1999; Lee et al., 1999; Monteil et al., 2000a,b) . In this article, we report the first electrophysiological study of the inhibitory effects of fluoxetine and norfluoxetine on the recombinant T-type Ca 2ϩ channels. channels are broadly involved in physiology, including cardiac pacemaker, hormone secretion, fertilization, neuronal firing, epilepsy, cardiac hypertrophy (Huguenard, 1996) , sleep (Anderson et al., 2005) , and pain (Todorovic et al., 2001; Bourinet et al., 2005) , their inhibition by fluoxetine should be investigated for a better understanding of this antidepressant's therapeutic action and side effects.
Materials and Methods
Cell Culture and Transfection Protocols. The tsA 201 cell line was cultivated in Dulbecco's modified Eagle's medium supplemented with glutamax and 10% fetal bovine serum (Invitrogen, Cergy-Pontoise, France). Transfection was performed using jet-polyethyleneimine (Qbiogene, Illkirch, France) with a DNA mix containing 10% of a green fluorescent protein plasmid and 90% of either one of the pCDNA3 plasmid constructs that codes for human Ca V 3.1 Perez-Reyes et al., 1998; Klugbauer et al., 1999; Lee et al., 1999; Monteil et al., 2000a,b) , Ca V 3.2 and Ca V 3.3 (Gomora et al., 2002) . Electrophysiological recordings were performed 2 to 4 days after transfection. A Chinese hamster ovary cell line stably expressing Cav3.1, isoform "bc" Perez-Reyes et al., 1998; Klugbauer et al., 1999; Lee et al., 1999; Monteil et al., 2000a,b; Chemin et al., 2001) , was used in some experiments, and no difference was observed in fluoxetine sensitivity between the two recipient cell models. The mouse neuroblastoma/rat glioma hybrid cell line NG 108-15 was cultured in Dulbecco's modified Eagle's medium supplemented with glutamax, 10% fetal bovine serum, and 2% hypoxanthine/aminopterine/thymidine (Invitrogen), as reported elsewhere (Chemin et al., 2002b) .
Electrophysiology and Calcium Current Analysis. Wholecell Ca 2ϩ currents were recorded at room temperature. Extracellular solution contained 2 mM CaCl 2 , 160 mM tetraethylammonium chloride, and 10 mM HEPES, pH to 7.4 with tetraethylammonium-OH. Pipettes had a resistance of 2 to 3 M⍀ when filled with a solution containing 110 mM CsCl, 10 mM EGTA, 10 mM HEPES, 3 mM Mg-ATP, and 0.6 mM GTP, pH to 7.2 with CsOH. The sampling frequency for acquisition was 10 kHz, and data were filtered at 2 kHz. For action potential clamp studies (Fig. 5) , a thalamocortical relay cell firing activity was generated using NEURON (Hines and Carnevale, 1997) . This simulation environment (available at http:// www.neuron.yale.edu/neuron/about/what.html) allows simulation of neuronal activities that can be used as waveforms in voltage-clamp experiments on Ca V -transfected cells (Chemin et al., 2002a) . The Ca 2ϩ current data were analyzed as described previously (Chemin et al., 2001) . Current-voltage relationships were fitted using a combined Boltzmann and linear ohmic relationships, where
To minimize the consequence of current rectification near reversal potential on the determination of conductance, the current values greater than ϩ30 mV were not considered for the fit. The normalized conductance-voltage curves were fitted with the following Boltzmann equation:
The steady-state inactivation curves were fitted using I/I max ϭ 1 Ϫ 1/(1 ϩ e (V1/2 Ϫ Vm)/slope ). Kinetics of the recovery from inactivation were calculated with a double-exponential expression:
), where A 1 and A 2 are the relative amplitudes of each exponential and t 1 and t 2 their respective time t constants. To better evaluate the role of fluoxetine on the recovery process, we defined the global recovery (t g ) as A 1 t 1 ϩ A 2 t 2 . The dose-response curves were fitted using a sigmoidal Hill function, I ϭ 1/(1 ϩ e (EC50 Ϫ Vm)/Hill slope ). Student's t tests were used to compare the different values and were considered significant at P Ͻ 0.05. Results are presented as the mean Ϯ S.E.M., and n is the number of cells used.
Pharmacological Agents. Fluoxetine and norfluoxetine were purchased from Sigma-Aldrich (Lyon, France). The drugs were dissolved in water at 10 mM as a stock solution and keep at Ϫ20°C.
Drugs were applied to cells by a gravity-driven perfusion device controlled by solenoid valves.
Results

Fluoxetine Inhibition of Recombinant T-Type Ca
2؉
Channels. Figure 1 shows typical trace recordings of Ca V 3 currents expressed in the tsA 201 cells. Application of fluoxetine (10-20 M) inhibits the three cloned T-type Ca 2ϩ channels ( Fig. 1 , A-C, left). A similar inhibition was obtained at every potential, as observed on the corresponding currentvoltage curves for Ca V 3.1, Ca V 3.2, and Ca V 3.3 currents (Fig.  1 , A-C, right). The fluoxetine block reached its maximum after ϳ40 s and was totally reversible upon washout, as illustrated for Ca V 3.3 currents (Fig. 1D ). The average current inhibition induced by 10 M fluoxetine was 42% (I/I Ctrl ϭ 0.58 Ϯ 0.02, n ϭ 12) for Ca V 3.1 currents, 43% (I/I Ctrl ϭ 0.57 Ϯ 0.01, n ϭ 7) for Ca V 3.2 currents, and 27% (I/I Ctrl ϭ 0.73 Ϯ 0.02, n ϭ 9) for Ca V 3.3 currents (Fig. 1E) . Likewise, in proliferative NG 180-15 cells that display native T-type Ca 2ϩ channels related to Ca V 3.2 channels (Chemin et al., 2002b) , ) elicited by a Ϫ30 mV test pulse (left) and on currentvoltage curves (right) obtained for Ca V 3.1 currents (A, squares; n ϭ 7) and Ca V 3.2 currents (B, circles; n ϭ 11) and 20 M fluoxetine on Ca V 3.3 currents (C, triangles; n ϭ 5). The holding potential during the interpulse (10 s) was Ϫ100 mV. D, time course of fluoxetine inhibition on Ca V 3.3 currents. E, comparison of the effect of 10 M fluoxetine on the Ca V 3.1, Ca V 3.2, and Ca V 3.3 currents elicited by a Ϫ30-mV test pulse and on T currents from proliferative NG 108-15 cells.
10 M fluoxetine inhibited T currents by 43% (I/I Ctrl ϭ 0.57 Ϯ 0.06, n ϭ 5; Fig. 1E ).
Ca V 3 Current Inhibition by Fluoxetine and Norfluoxetine Is Concentration-Dependent. Increasing concentrations of fluoxetine and norfluoxetine were then applied to tsA201 cells expressing the various T-type Ca 2ϩ channels (Fig. 2) . The T-current inhibition was concentration-dependent for Ca V 3.1, Ca V 3.2, and Ca V 3.3 channels (Fig. 2, A and  B) . Analysis of the dose-response curves of fluoxetine revealed IC 50 values of 14.5 Ϯ 1.1 M (n ϭ 6) for Ca V 3.1 currents, 15.9 Ϯ 1.3 M (n ϭ 7) for Ca V 3.2 currents, and 31.1 Ϯ 3.5 M (n ϭ 7) for Ca V 3.3 currents (Fig. 2B) . Hill slope factors were 0.9 Ϯ 0.1, 0.8 Ϯ 0.1, and 0.6 Ϯ 0.1, for Ca V 3.1, Ca V 3.2, and Ca V 3.3 currents, respectively (Fig. 2B) . Norfluoxetine, the active metabolite of fluoxetine, was more potent than the parent molecule in blocking Ca V 3 currents, as illustrated for Ca V 3.3 currents (Fig. 2, C and D) . As for fluoxetine, norfluoxetine produced a concentration-dependent block of the recombinant T-type Ca 2ϩ channels (Fig. 2, E and F) . The IC 50 values obtained with norfluoxetine were 13.8 Ϯ 0.1 M (n ϭ 5), 7.01 Ϯ 0.03 M (n ϭ 3), and 5.5 Ϯ 0.2 M (n ϭ 3) for Ca V 3.1, Ca V 3.2, and Ca V 3.3 currents, respectively, whereas the Hill slope factors were 1.35 Ϯ 0.03, 1.58 Ϯ 0.03, and 2.93 Ϯ 0.02 for Ca V 3.1, Ca V 3.2, and Ca V 3.3 currents, respectively (Fig. 2F) .
Effects of Fluoxetine on the Steady-State Inactivation of Ca V 3 Currents. Next, we investigated whether the effects of fluoxetine on T-type Ca 2ϩ currents would be statedependent. A double-pulse protocol was used to assess whether fluoxetine affects the voltage dependence of the steady-sate inactivation of Ca V 3 channels. A family of Ca V 3.1 currents evoked by this protocol is depicted in Fig. 3A before (top traces) and during application of 10 M fluoxetine (bottom traces). Fluoxetine significantly shifted the steady-state inactivation curves of Ca V 3.1 currents toward hyperpolarized potentials from Ϫ75.7 Ϯ 0.6 mV in control condition to Ϫ86.7 Ϯ 1 mV (10 M fluoxetine, n ϭ 9; Fig. 3B ). A slight shift (2 mV), but not statistically significant, was observed in the steady-state activation curve (Fig. 3B) . Neither activation nor inactivation kinetics were changed after fluoxetine treatment for Ca V 3.1 currents or for Ca V 3.2 and Ca V 3.3 currents (data not shown). As a consequence of the steadystate inactivation shift, the window current (or steady-state current) generated by the Ca V 3.1 subunit was markedly decreased (Fig. 3B) . Similar results were obtained with the Ca V 3.2 and Ca V 3.3 subunits (Fig. 3C ). In the presence of 10 The steady-state inactivation was estimated from the variation of the current amplitude at Ϫ30 mV after a 5-s predepolarization of increasing amplitude (Ϫ110 to Ϫ40 mV with 5-mV increments). B, normalized steady-state activation and inactivation curves for the Ca V 3.1 subunit in the presence (Ⅺ) and in the absence (f) of 10 M fluoxetine (fluo.). Steady-state activation curves were obtained from the current-voltage curve presented in Fig. 1 [V 0.5 ϭ Ϫ56.4 Ϯ 1.1 mV for control and V 0.5 ϭ Ϫ58.4 Ϯ 0.9 mV (n ϭ 7) in the presence of 10 M fluoxetine, P ϭ 0.18], whereas steady-state inactivation curves were obtained from the protocol described in A. C, effects of 10 M fluoxetine on the V 0.5 value of the steady-state inactivation for the three Ca V 3 subunits (n ϭ 10, 15, and 11). D, block of Ca V 3.3 currents by fluoxetine was dependent on the HP. M fluoxetine, the half-potential (V 0.5 ) of steady-state inactivation was shifted approximately 10 mV toward the hyperpolarized potential for the three T-type Ca 2ϩ channel subunits (Fig. 3C) , whereas no significant change was observed for the corresponding slope factors for Ca V 3.1, Ca V 3.2, and Ca V 3.3 subunits. Such an effect on the voltage dependence of the steady-state inactivation suggests that fluoxetine interacts with the inactivated state of the channels. A direct method to evaluate fluoxetine binding onto inactivated T channels was to measure current inhibition at various holding potentials (HPs). The inhibition of Ca V 3.1 currents by 10 M fluoxetine was examined for HPs of Ϫ100 and Ϫ80 mV (Fig. 3D) . As expected, 10 M fluoxetine strongly blocked Ca V 3.1 currents at HP Ϫ80 mV (by 85 Ϯ 1%, n ϭ 5), whereas at HP Ϫ100 mV, fluoxetine reduced Ca V 3.1 currents by 41 Ϯ 2% (n ϭ 5).
Fluoxetine Inhibition of T-Type Ca
Fluoxetine Slows the Recovery from Inactivation of Ca V 3 Currents. To determine whether the channel is maintained as blocked in the inactivated state by fluoxetine, we investigated the recovery from short inactivation using a two paired-pulse protocol (Fig. 4) . Figure 4A shows typical examples of current traces recorded for different values of interpulse intervals for Ca V 3.1 currents in the absence (top traces) and presence of 10 M fluoxetine (bottom traces). The time course of the recovery process was then plotted (Fig. 4B) , showing that fluoxetine significantly slowed t g , the time constant, the global recovery from short inactivation, by a factor of approximately 2 for Ca V 3.1 (188 Ϯ 21 and 391 Ϯ 20 ms before and after fluoxetine application, respectively; n ϭ 7) and Ca V 3.2 (381 Ϯ 28 and 706 Ϯ 45 ms before and after fluoxetine application, respectively; n ϭ 5) currents, whereas these effects were not significant for Ca V 3.3 currents at this holding potential (250 Ϯ 49 and 390 Ϯ 68 ms, before and after fluoxetine application, respectively; n ϭ 10; Fig. 4 , B and C).
Enhanced Fluoxetine Inhibition of Ca V 3 Currents in Action Potential Clamp Experiments. Both the slowing in the recovery kinetics and the decrease in the window current component in the presence of fluoxetine strongly suggested that this drug would be a potent inhibitor of Ca V 3 currents involved in neuronal firing activities. To appreciate better the physiological impact of the fluoxetine block of T currents, we performed voltage-clamp experiments on transfected cells using a thalamocortical relay cell-firing activity generated with the NEURON model as waveform (Fig. 5A , see Materials and Methods). As observed previously (Kozlov et al., 1999; Chemin et al., 2002a) , the Ca V 3.3 currents strongly participate in the Ca 2ϩ entry during sustained neuronal activities (Fig. 5B ). Fluoxetine application (1 and 10 M) strongly decreased the amplitude of Ca V 3.3 currents and accelerated the decay of Ca 2ϩ entry through Ca V 3.3 channels (Fig. 5, C and D) . To quantify these effects, we measured the integral of the inward Ca 2ϩ currents before (Ctrl) and after application of fluoxetine (1 and 10 M) and norfluoxetine (1 M). Application of 1 M fluoxetine and norfluoxetine on Ca V 3.3 currents resulted in 47% of inhibition (I/I Ctrl ϭ 0.53 Ϯ 0.11, n ϭ 6) and 74% of inhibition (I/I Ctrl ϭ 0.26 Ϯ 0.09, n ϭ 5), respectively (Fig. 5, C and E) . The average current inhibition induced by 10 M fluoxetine was 82% for Ca V 3.3 currents (I/I Ctrl ϭ 0.18 Ϯ 0.02, n ϭ 8), 93% for Ca V 3.1 currents (I/I Ctrl ϭ 0.07 Ϯ 0.01, n ϭ 7), and 86% for Ca V 3.2 currents (I/I Ctrl ϭ 0.14 Ϯ 0.02, n ϭ 9) (Fig. 5E ). Considering the significant block of micromolar concentrations of both fluoxetine and norfluoxetine in action potential clamp experiments, the data strongly suggest that fluoxetine inhibition of Fig. 4 . Fluoxetine slows the recovery from inactivation of Ca V 3 currents. A and B, effects of 10 M fluoxetine (fluo.) on the time course of recovery from short inactivation for Ca V 3.1 currents at a HP of Ϫ100 mV. Recovery from short inactivation was measured using a double pulse at Ϫ30 mV (lasting 100 ms) with an interpulse at Ϫ100 mV of increasing duration. C, effects of 10 M fluoxetine on the of recovery for the three Ca V 3 subunits. The of recovery was deduced from the curves presented in B (see Materials and Methods). 5 . Fluoxetine strongly blocked Ca V 3.3 currents during thalamic relay cell-like activities. A, firing activity typical of those recorded on thalamic relay neurons was used as waveform (action potential clamp) to induce Ca 2ϩ currents in a cell expressing Ca V 3.3 channels (B). C and D, fluoxetine strongly blocked Ca V 3.3 current during thalamic relay cell-like activities at 1 M (C) and 10 M (D). Traces presented in B, C, and D were obtained on the same cell. E, normalized integral of the total current generated by the three Ca V 3 subunits during thalamic relay cell-like activities in the presence of 1 M fluoxetine (n ϭ 6), 1 M norfluoxetine (n ϭ 5), and 10 M fluoxetine (n ϭ 7 for Ca V 3.1, n ϭ 9 for Ca V 3.2, and n ϭ 8 for Ca V 3.3). 
Discussion
The main finding of the present study is that fluoxetine inhibits the three Ca V 3 T-type Ca 2ϩ channel isotypes as expressed in human embryonic kidney 293/tsA 201 cells. We describe that fluoxetine preferentially binds to inactivated T-type Ca 2ϩ channels and stabilizes them in their inactivated state. We also provide evidence that fluoxetine can strongly inhibit T-type Ca 2ϩ channels during neuronal firing activities. Altogether, our data significantly extend a previous electrophysiological study, the first to our knowledge, describing that fluoxetine inhibits voltage-gated calcium channels, including T-type Ca 2ϩ channels, in rat hippocampal pyramidal cells (Deak et al., 2000) . Moreover, we report that norfluoxetine, the major active metabolite of fluoxetine, is even more potent that the parent molecule in blocking T-type Ca 2ϩ channels. Recombinant Ca V 3 channels are efficiently inhibited by micromolar concentrations of fluoxetine and norfluoxetine. It is noteworthy that the use of neuronal activities clearly shows that a 1 M concentration of both fluoxetine and norfluoxetine significantly inhibited neuronal T-type Ca 2ϩ channels (47 and 74% inhibition, respectively, for Ca V 3.3 current; Fig. 5 ). The therapeutic plasma concentration of fluoxetine is estimated between 0.15 and 1.5 M (Orsulak et al., 1988; Altamura et al., 1994) . Under steady-state conditions, the plasma concentrations of norfluoxetine are higher than those of fluoxetine (Altamura et al., 1994) , and for both compounds, it was shown that brain concentration can reach much higher levels during long-term fluoxetine treatment (Karson et al., 1993) . In addition, in elderly patients, decreased elimination increases the plasma concentration of fluoxetine (Pato et al., 1991; Borys et al., 1992) . For all of these reasons, the fluoxetine concentrations that block Ttype Ca 2ϩ channels are within the range of those observed clinically after oral administration of the drug, and a significant reduction of these channels may occur in patients who receive long-term treatment with fluoxetine.
The IC 50 values obtained with fluoxetine for blocking Ttype Ca 2ϩ channels are similar to those obtained for the inhibition of other ionic channels in different preparations. For example, the IC 50 values of fluoxetine block of cloned shaker potassium channel (Kv1.3 and Kv1.4) and voltageactivated potassium channel (hsK1-3) range between 3 and 33 M (Choi et al., 1999 (Choi et al., , 2003 Terstappen et al., 2003) . We show that norfluoxetine is more potent than fluoxetine in inhibiting Ca V 3 channels, especially Ca V 3.3 currents. Likewise, it has been reported that norfluoxetine is a more potent and more selective 5-hydroxytryptamine reuptake inhibitor than fluoxetine (Hiemke and Hartter, 2000) and produced a stronger inhibitory effect than fluoxetine on Kv1.3 currents (Choi et al., 1999) .
Inhibition of recombinant T-type Ca 2ϩ channels is highly dependent on their inactivation state. Indeed, fluoxetine induces an approximately Ϫ10 mV shift of the steady-state inactivation curves for each T-channel isotype without having a statistically significant effect on the activation curves. Therefore, fluoxetine block is more potent at a physiological holding potential for which T-channels are inactivated (Huguenard, 1996) . These results and the fact that fluoxetine slows the recovery kinetics from inactivation indicate that this drug interacts with inactivated T channels and maintains the channels in the inactivated state. These findings contrast with mechanistic studies on other ionic conductances showing that fluoxetine binds to the open state of cloned nicotinic acetylcholine receptor and Kv1.4 channels (Garcia-Colunga et al., 1997) . Binding to the inactivated Ttype Ca 2ϩ channels is an important feature of the fluoxetine block, because this property could also contribute to tissue selectivity of the fluoxetine effects. For example, dihydropyridines that bind preferentially to the inactivated state of L-type Ca 2ϩ channels are useful as antihypertensive drugs by acting on vascular smooth muscle while having little effect on the heart (Triggle, 1992) .
By stimulating tsA 201 cells overexpressing Ca V 3 channels with firing activities typical of thalamocortical relay neurons, we demonstrate that fluoxetine block of T currents is more potent during physiological stimulations. This suggests that fluoxetine could be an important regulator of firing activities dependent on T-type Ca 2ϩ channels (Destexhe et al., 1998) . For example, the mechanism of T-type Ca 2ϩ channels inhibition by fluoxetine (binding to and stabilization of the inactivated T-type Ca 2ϩ channels) suggests that this drug could impair low-threshold spikes related to T channels in the thalamus (Huguenard and Prince, 1992; Huguenard, 1996; Destexhe et al., 1998) . Thalamic T channels are involved in slow-wave sleep (Anderson et al., 2005) , and fluoxetine block of T-type Ca 2ϩ channels may explain insomnia, a side effects of this drug (Gram, 1994) . T-type Ca 2ϩ channels of the thalamus are also involved in the pathogenesis of epilepsy (Tsakiridou et al., 1995) . In animal models of epilepsy, fluoxetine decreases the probability of audiogenic convulsions in genetically seizure-prone rodents and hippocampal seizures in rat (Prendiville and Gale, 1993; Wada et al., 1995) . The anticonvulsant action of fluoxetine has been observed both in animal and human studies. Again, anticonvulsive properties of fluoxetine (Leander, 1992; Prendiville and Gale, 1993; Wada et al., 1995) could be related to the block of thalamic T-type Ca 2ϩ channels. In addition, fluoxetine enhances the effects of various conventional anticonvulsants in mice, such as phenytoin (Leander, 1992) , which also inhibits T currents (Todorovic et al., 2000) . Fluoxetine may also affect non-neuronal T-type Ca 2ϩ channels. Indeed, cardiac T-type Ca 2ϩ channels participate in the control of the pacemaker activity (Lei and Kohl, 1998) , and their inhibition by fluoxetine may explain the bradycardia induced by this drug . In addition, we observed a net decrease in the window current component of cloned T-type Ca 2ϩ channels. This effect on window current may explain the relaxation induced by fluoxetine on vascular smooth muscles (Farrugia, 1996) by decreasing intracellular calcium levels.
In summary, the data presented here show that fluoxetine (Prozac) potently inhibits the three T-type Ca 2ϩ channel isotypes. Fluoxetine preferentially blocks inactivated T-type Ca 2ϩ channels, which corresponds to their status in physiological conditions. Indeed, inhibition of T-type Ca 2ϩ channels represents a novel mechanism by which fluoxetine is pharmacologically active and could account for some of the clinical effects in treated patients. Fluoxetine inhibition of T-type Ca 2ϩ channels should therefore be taken into account in further studies investigating the pharmacological properties of this widely prescribed antidepressant.
